- Home
- Public Health
- MedX Weekly: FDA Clears New RRP & Fibromyalgia Therapies, Lisaftoclax Enters Global Phase 3 Study & More

1d4 min read
Medical Article
Hello, and a warm welcome to MedX, where we bring you the latest news and insights from the world of medicine. FDA Approves Zopapogene Imadenovec for Recurrent Respiratory Papillomatosis The FDA has approved zopapogene imadenovec, a novel adenoviral vector-based immunotherapy, for adult patients with recurrent respiratory papillomatosis. This rare
MedX Weekly: FDA Clears New RRP & Fibromyalgia Therapies, Lisaftoclax Enters Global Phase 3 Study & More
Similar Content

Pancytopenia, a rare presentation of hyperthyroidism
830 Reached2 Comments

Male Complaining of Bilateral Knee Pain and Gait Disturbance
840 Reached5 Comments1 Likes

Young Girl Presented with Irritability and Abnormal Behavior
2250 Reached10 Comments4 Likes

Case of Pulmonary Embolism with Syncope
544 Reached4 Likes

Management of Infantile Myoclonic Seizures
1169 Reached3 Comments3 Likes